Study | Number of patients (total/FU) | Histological subtype (T, A, M) | Median follow-up (months) | Follow-up information | Outcome |
---|---|---|---|---|---|
Enzinger et al. [1] | 59/41 | N/A | N/A | 11 LR 1 DM | 3 DoC |
Folpe et al. [6] | 70/51 | N/A | 36 | 9 LR 8 DM | 41 NED 6 ED 4 DoD 1 DoC |
Miettinen et al. [3] | 104/41 | N/A | 156 | 9 LR | 32 UNK 16 DoC 5 NED |
Graham et al. [15] | 46/27 | TÂ =Â 26 AÂ =Â 5Â MÂ =Â 15 | 55 | 2 LR (M) 3 DM (M) | 3 DoD |
Atanaskova Mesinkova et al. [4] | 26/16 | TÂ =Â 8 AÂ =Â 13Â MÂ =Â 5 | 45 | 3 LR (M) 1 DM (M) | N/A |
Kossivi Dantey et al. [5] | 6/6 | AÂ =Â 1Â MÂ =Â 5 | 27 | No events | 1 DoC |